© 2022 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Dr Laura Periman, MD discusses biopsychosocial and economic impacts, as well as innovative treatment opportunities for patients with dry eye disease.
June 7th 2022
Dr Laura Periman, MD illustrates the current risk factors and prevalence regarding patients with dry eye disease.
June 14th 2022
Quality-of-life concerns, including biopsychosocial impacts caused by dry eye disease, are explored by Dr Periman.
June 21st 2022
Dr Periman addresses cost-related concerns associated with treating dry eye disease.
June 28th 2022
Various treatments for dry eye disease are navigated with regard to both payer and provider considerations.